background
viral
diseas
infect
control
cellular
level
type
interferon
ifni
dengu
viru
denv
abil
inhibit
respons
type
iii
interferon
also
known
lambda
ifn
ifniii
complementari
pathway
antivir
respons
ifni
work
analyz
ifniii
mediat
antivir
respons
denv
serotyp
infect
method
dengu
fever
patient
sampl
determin
level
elisa
studi
respons
denv
infect
select
epitheli
cell
line
demonstr
permiss
infect
effect
viru
replic
determin
cell
parallel
express
ifnstimul
gene
isg
suppressor
cytokin
signal
soc
gene
measur
rtqpcr
result
found
increas
time
serolog
dengu
fever
patient
compar
healthi
blood
donor
inhibit
replic
dosedepend
manner
vitro
reduct
viral
titer
correspond
increas
isg
mrna
level
highest
inhibit
occur
isg
peak
express
presenc
ifnneg
regul
infect
associ
reduc
express
conclus
evid
describ
suggest
good
candid
inhibitor
viral
replic
dengu
infect
mechan
cellular
organism
interplay
denv
need
studi
could
provid
insight
strategi
treat
diseas
furthermor
report
novel
epitheli
model
studi
dengu
infect
vitro
dengu
import
public
health
problem
use
updat
map
approach
million
estim
dengu
infect
per
year
worldwid
million
manifest
clinic
level
sever
lead
half
million
hospit
death
mainli
children
etiolog
agent
dengu
diseas
dengu
viru
denv
respons
dengu
fever
df
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
dengu
viru
member
flavivirida
famili
envelop
viru
contain
kb
genom
posit
singlestrand
rna
encod
three
structur
protein
c
prm
e
seven
nonstructur
protein
four
serotyp
dengu
viru
caus
df
sever
manifest
like
dhf
dss
dengu
viru
transmit
femal
mosquito
mainli
speci
aed
aegypti
albopictu
diseas
widespread
throughout
tropic
local
spatial
risk
variat
influenc
strongli
rainfal
temperatur
unplan
rapid
urban
mani
viral
diseas
infect
control
cellular
level
type
interferon
produc
respons
viral
rna
recognit
ifni
specif
cell
receptor
activ
jakstat
signal
pathway
lead
establish
antivir
state
cell
howev
virus
possess
divers
strategi
circumv
ifn
effect
denv
like
virus
abil
inhibit
innat
respons
may
contribut
pathogenesi
denv
viru
induc
activ
releas
high
level
chemokin
proinflammatori
cytokin
human
dendrit
cell
although
weak
induc
ifni
block
phosphoryl
impair
subsequ
product
three
type
ifn
type
compris
sever
subtyp
sever
isoform
type
ii
contain
one
member
latest
identifi
group
type
iii
compris
also
name
interleukin
il
respect
limit
inform
express
biolog
function
furthermor
role
ifniii
denv
infect
unexplor
specif
signal
occur
receptor
cell
membran
consist
two
subunit
also
name
receptor
cell
express
subunit
distribut
appear
much
restrict
receptor
express
preferenti
cell
epitheli
origin
cell
immun
system
bind
receptor
lead
activ
mediat
phosphoryl
protein
stat
phosphoryl
lead
dimer
bind
transloc
nucleu
regul
express
specif
gene
ifniii
similar
function
ifni
induc
antivir
state
cell
mediat
antivir
respons
sever
human
pathogen
includ
hepat
b
viru
hepat
c
viru
human
immunodefici
viru
restrict
express
receptor
suggest
could
exert
antivir
role
certain
cell
type
commerci
vaccin
specif
antivir
treatment
dengu
thu
develop
effici
therapeut
strategi
common
sometim
sever
infect
urgent
antivir
activ
interferon
observ
divers
clinic
studi
show
rel
effici
differ
viral
infect
limonta
vidal
et
al
introduc
use
leukocyt
interferon
treat
children
dengu
show
signific
decreas
number
complic
death
interferon
appli
howev
clinic
use
interferon
treat
dengu
common
possibl
due
side
effect
associ
system
activ
attract
treatment
altern
elicit
satisfactori
antivir
activ
minor
secondari
respons
nevertheless
denv
develop
mechan
evad
immun
respons
therefor
precis
analysi
respons
dengu
infect
crucial
evaluatepredict
potenti
clinic
use
diseas
present
work
focus
effect
epitheli
cell
ifniii
infect
found
higher
level
dengu
fever
patient
compar
healthi
blood
donor
provid
evid
endogen
exogen
inhibit
replic
cell
line
detect
presenc
denv
infect
serum
sampl
patient
dengu
fever
analyz
elisa
level
determin
serum
sampl
patient
dengu
fever
healthi
blood
donor
figur
show
valu
distribut
group
mean
pgml
df
patient
pgml
p
healthi
donor
studi
respons
infect
select
epitheli
cell
line
denv
infect
report
infect
cell
perform
initi
assay
analyz
whether
cell
permiss
infect
replic
cell
viral
titer
supernat
h
postinfect
quantifi
lytic
plaqu
assay
cell
mean
infecti
viral
progeni
releas
cell
immunofluoresc
analysi
use
specif
antibodi
denv
prm
protein
fig
confirm
cell
fig
dengu
fever
patient
enhanc
level
blood
level
pgml
serum
clinic
dengu
patient
healthi
donor
measur
elisa
experi
done
triplic
reproduc
error
bar
repres
standard
deviat
mean
p
permiss
infect
specif
fluoresc
found
cytoplasm
infect
cell
data
propos
cell
line
novel
epitheli
model
analyz
relationship
infect
analyz
effect
infect
signal
transduct
initi
ifniii
tissuespecif
subunit
typeiii
interferon
receptor
quantifi
cell
immunofluoresc
figur
show
presenc
signific
level
cell
membran
noninfect
cell
red
signal
express
subunit
increas
presenc
fig
infect
fig
respect
untreat
cell
quantif
shown
fig
thu
upregul
similar
extent
express
subunit
ifniii
receptor
suggest
differenti
effect
two
stimuli
may
lie
point
signal
transduct
pathway
determin
whether
induc
express
subtyp
four
treatment
compar
mock
infect
treatment
ng
ml
denvinfect
moi
treatment
follow
denv
infect
mockinfect
cell
rtpcr
product
isoform
fig
contrast
transcript
demonstr
endpoint
rtpcr
three
condit
studi
fig
corrobor
result
total
protein
extract
condit
use
western
blot
specif
antibodi
two
subtyp
ifniii
figur
show
strongli
induc
infect
explor
effect
infect
replic
inhibit
curv
determin
cell
pretreat
increas
concentr
ngml
iuml
prior
infect
moi
fortyeight
hour
infect
supernat
condit
quantifi
lytic
plaqueform
assay
fig
figur
show
inhibit
replic
dosedepend
manner
rel
high
inhibitori
effect
ngml
ngml
fig
ngml
ngml
fig
wherea
iuml
iuml
fig
experi
show
exogen
administr
prior
infect
reduc
viral
titer
subsequ
viral
replic
cell
determin
lytic
plaqueform
assay
differ
time
postinfect
h
two
infecti
dose
moi
assay
cell
pretreat
ngml
fig
fig
h
prior
infect
compar
cell
infect
treat
ifn
plot
show
equival
effect
pretreat
viral
titer
reduc
log
respect
mocktreat
cell
determin
whether
enough
inhibit
replic
test
abil
inhibit
viral
replic
absenc
inhibit
experi
similar
describ
fig
perform
vero
cell
produc
yet
respond
suppli
extern
vero
cell
preincub
h
increas
concentr
plu
infect
treatment
decreas
viral
progeni
ngml
fig
treatment
plu
lower
ngml
calcul
fig
treatment
alon
could
nt
calcul
e
f
treat
ngml
immunofluoresc
detect
secondari
antibodi
observ
fluoresc
microscopi
magnif
g
fluoresc
intens
determin
analysi
three
differ
field
randomli
count
cell
use
imag
analysi
softwar
p
p
nuclei
stain
green
fluoresc
dye
bar
inhibit
reach
experiment
condit
fig
experi
suggest
abl
inhibit
infect
effect
respons
like
involv
type
interferon
possibl
synerg
express
kinet
ifnstimul
gene
isg
analyz
cell
quantit
realtim
pcr
rtqpcr
experiment
group
describ
fig
mock
infect
treatment
denvinfect
follow
denv
infect
analysi
select
gene
indic
interferon
pathway
function
antivir
respons
gene
two
neg
regulatori
gene
figur
show
stimul
cell
slightli
increas
transcript
similar
level
h
posttreat
pt
infect
significantli
increas
mrna
earlier
time
peak
h
postinfect
howev
strike
effect
present
pretreat
follow
infect
show
pronounc
increas
express
h
postinfect
time
peak
underw
slow
steadi
decreas
remain
b
extract
total
protein
condit
use
western
blot
determin
presenc
protein
actin
load
control
semi
quantit
analysi
detect
band
normal
actin
perform
use
imagej
softwar
http
rsbinfonihgovij
high
h
result
suggest
decreas
replic
part
viral
mrna
degrad
via
rnase
l
moreov
stimul
cell
dramat
increas
gene
transcript
suggest
effici
activ
ifniii
signal
transduct
use
control
infect
treatment
induc
bimod
increas
first
peak
h
postinfect
second
peak
nearli
higher
basal
h
fig
bimod
probabl
due
result
first
wave
activ
subsequ
increas
h
could
demonstr
late
induct
well
late
wave
endogen
interferon
mrna
detect
similar
level
infect
noninfect
cell
studi
time
suggest
denv
induc
impair
ifn
signal
transduct
howev
experi
discrimin
ifni
ifniii
specif
pathway
cell
pretreat
infect
mrna
increas
h
postinfect
although
much
determin
differenti
effect
activ
ifni
ifniii
mrna
level
ifni
ifniii
quantifi
figur
show
mrna
increas
cell
infect
studi
time
stimul
increas
time
h
posttreat
contrast
pretreat
follow
infect
show
increas
mrna
remain
much
lower
stimul
alon
therefor
believ
could
affect
transcript
gene
probabl
affect
irf
contrast
three
experiment
condit
induc
intens
bimod
stimul
express
peak
h
post
treatment
fig
treatment
alon
increas
mrna
h
h
posttreat
treatment
follow
infect
increas
level
somewhat
less
h
h
postinfect
respect
similar
express
kinet
fig
c
contrast
fig
suggest
inhibit
transcript
infect
could
due
primarili
lack
ifni
import
factor
ifn
pathway
neg
regul
increas
h
post
infect
fig
f
noteworthi
infect
induc
signific
increas
peak
h
wherea
stimul
subsequ
infect
increas
impair
reach
h
order
analyz
aspect
express
kinet
data
fig
replot
fig
group
experiment
condit
control
cell
mockinfect
show
signific
activ
gene
test
indic
extern
stimulu
requir
activ
transcript
evalu
condit
fig
mrna
peak
h
h
posttreat
fig
infect
stimul
transcript
maximum
valu
h
posttreat
lower
treat
cell
open
circl
fig
vs
c
highest
mrna
level
observ
cell
treat
h
postinfect
fig
infect
increas
transcript
compar
noninfect
cell
treat
convers
highest
level
transcript
observ
group
h
h
fig
addit
steadi
increas
start
h
postinfect
reach
observ
group
fig
increas
smaller
cell
stimul
fig
particular
interest
group
show
signific
increas
express
evalu
time
ifn
neg
regul
show
maximum
amount
h
h
poststimul
infect
also
elicit
increment
express
much
stronger
activ
coincid
observ
infect
even
stronger
experiment
condit
show
highest
express
gene
h
postinfect
drop
express
level
h
postinfect
also
evid
peak
see
figur
previou
page
fig
inhibit
replic
cell
lack
type
ifn
vero
cell
treat
increas
concentr
b
plu
c
infect
moi
dose
use
ngml
uiml
fortyeight
hour
postinfect
viral
titer
obtain
plaqu
assay
plot
show
percentag
inhibit
viral
titer
group
compar
untreat
cell
dot
line
repres
ic
valu
correspond
ngml
presenc
ngml
valu
calcul
inhibit
reach
condit
experi
error
bar
repres
standard
deviat
mean
two
independ
experi
p
p
ifniii
recent
identifi
interferon
group
limit
inform
express
biolog
function
particular
role
ifniii
denv
infect
unexplor
although
cell
respond
ifni
certain
cell
type
especi
epitheli
cell
respond
ifniii
due
restrict
receptor
express
present
work
demonstr
dengu
fever
patient
time
higher
level
compar
healthi
blood
donor
p
conduct
studi
answer
whether
play
role
viral
clearanc
gener
specif
clinic
outcom
instanc
recent
studi
found
higher
level
df
dhf
patient
infect
declin
rapidli
day
fever
onset
studi
requir
analysi
mani
patient
determin
diseas
sever
inclus
patient
infect
differ
denv
serotyp
among
variabl
epitheli
cell
ifniii
main
target
analysi
receptor
express
mous
cell
show
vagin
epithelium
keratinocyt
fibroblast
respond
sever
studi
conduct
cell
line
primari
cell
cultur
studi
respons
present
studi
found
cervic
epitheli
cell
line
permiss
infect
cell
line
produc
respond
essenti
support
antivir
action
express
cell
express
induc
viral
infect
concurr
express
accordingli
express
increas
infect
cell
could
potenti
effect
signal
lead
stimul
gene
transcript
antivir
respons
inhibit
replic
demonstr
hcv
hiv
hbv
infect
present
studi
demonstr
abil
inhibit
replic
reduc
amount
infecti
particl
secret
supernat
cultur
quantifi
plaqu
assay
treatment
decreas
viral
titer
doserespons
experi
show
valu
ngml
ngml
respect
fig
view
valu
test
whether
concentr
ngml
produc
optim
gene
induct
viral
infect
could
induc
express
antivir
respons
gene
dengu
infect
studi
involv
west
nile
viru
wnv
anoth
member
flavivirida
famili
induct
jakstat
pathway
activ
demonstr
infect
cell
abl
prevent
wnv
infect
cell
fail
inhibit
viral
replic
cell
infect
establish
like
due
inhibit
furthermor
report
inhibit
replic
vero
cell
devoid
ifni
function
ifniii
respons
data
suggest
dengu
viru
treatment
activ
isg
without
type
ifn
howev
pretreat
dengu
infect
abl
inhibit
viral
replic
degre
vero
cell
show
dengu
viru
block
activ
signal
pathway
induc
type
iii
interferon
sinc
viral
titer
decreas
markedli
highest
dose
use
data
suggest
viral
replic
inhibit
albeit
weakli
endogen
exogen
complet
absenc
ifni
furthermor
reduct
viral
progeni
observ
suggest
interferon
work
synergist
importantli
gene
induc
vero
cell
stimul
recombin
type
interferon
thu
demonstr
although
cell
nt
produc
ifni
respond
antivir
effect
shown
ifniii
could
occur
stimul
antivir
gene
cell
first
treat
infect
noteworthi
infect
induc
isg
transcript
reach
level
observ
cell
stimul
howev
cell
pretreat
infect
isg
transcript
level
significantli
higher
maintain
longer
group
induc
isg
reach
highest
peak
may
denot
neg
action
exert
ifnactiv
jakstat
pathway
howev
analyz
isg
presenc
stimul
remain
low
level
suffici
reach
second
express
peak
capabl
inhibit
viral
replic
late
stage
explain
decreas
viral
titer
observ
h
fig
antivir
gene
show
earli
activ
h
peak
h
respect
group
mrna
higher
cell
pretreat
subsequ
infect
compar
cell
stimul
outcom
like
due
increas
activ
gene
presenc
infect
plu
gene
activ
mediat
interferon
antivir
activ
infect
oasrnas
l
antivir
system
induc
via
ifn
play
critic
role
innat
immun
control
product
viral
particl
rnase
l
possess
antivir
action
cleav
viral
rna
induc
apoptosi
infect
cell
increas
product
higher
activ
gene
occur
stimul
genespecif
interferon
respons
indic
proper
function
pathway
cell
line
case
experi
increas
express
like
caus
pretreat
group
show
transcript
increas
gene
signific
although
transcript
level
high
cell
stimul
observ
level
may
suffici
inhibit
viral
replic
even
activ
soc
gene
whose
level
appear
suffici
complet
inhibit
transcript
later
time
transcript
level
isg
differ
group
show
clear
relationship
treatment
role
inhibit
replic
possibl
observ
process
evas
immun
respons
like
mediat
viral
infect
show
decreas
transcript
evalu
isg
infect
cell
compar
cell
stimul
increas
gene
howev
gene
activ
initi
last
time
evalu
h
postinfect
suggest
escap
suppressor
activ
soc
protein
cell
stimul
infect
slight
steadi
increas
evalu
isg
peak
h
postinfect
suggest
activ
pathway
partial
affect
viral
evas
find
suggest
ifni
ifniii
alway
concomitantli
express
support
idea
differ
regulatori
mechan
express
group
gene
individu
jointli
activ
noteworthi
highest
peak
evalu
isg
h
correspond
time
viral
titer
reduc
cultur
supernat
thu
greater
inhibit
viral
titer
achiev
isg
reach
peak
h
find
suggest
inhibit
viral
titer
caus
treatment
activ
gene
respons
interferon
whose
antivir
action
cell
inhibit
replic
product
increas
treatment
prior
viral
infect
result
suggest
ifniii
enhanc
express
ifni
pretreat
increas
express
infect
dengu
viru
lead
us
propos
crosstalk
interferon
type
iii
pathway
may
exist
cell
like
mononuclear
plasmacytoid
dendrit
cell
produc
respond
type
interferon
howev
necessarili
redund
system
shown
experi
wherein
express
exist
despit
evas
immun
respons
mount
absenc
antivir
drug
denv
paper
suggest
interferon
lambda
could
valuabl
candid
explor
clinic
studi
addit
immunomodulatori
properti
report
contribut
regul
inflammatori
process
characterist
dengu
studi
japanes
enceph
model
shown
decreas
inflamm
treatment
side
effect
associ
ubiquit
express
receptor
contrast
narrow
express
type
iii
interferon
receptor
could
consider
diminish
side
effect
clinic
use
first
report
increas
level
ifniii
dengu
fever
patient
vivo
antivir
effect
ifniii
infect
vitro
howev
aspect
activ
pathway
crosstalk
ifni
remain
unansw
epitheli
cell
line
use
model
vitro
mechanist
studi
denv
replic
interact
innat
respons
led
ifniii
infect
studi
inhibit
replic
dosedepend
manner
vero
cell
produc
viral
replic
inhibit
exogen
also
observ
although
higher
concentr
suggest
inhibit
infect
howev
potenti
decreas
viral
load
increas
presenc
infect
induc
express
exogen
induc
transcript
sever
isg
whose
express
peak
correspond
time
viral
titer
reduc
cultur
supernat
h
postinfect
present
work
open
possibl
studi
interact
mechan
denv
infect
ifniii
cell
model
present
opportun
consid
type
ifn
feasibl
candid
inhibit
infect
dengu
patient
human
cervic
carcinoma
atcc
african
green
monkey
kidney
vero
atcc
kindli
donat
dr
judith
universidad
del
estado
de
morelo
mexico
babi
hamster
kidney
atcc
cell
line
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
calf
serum
uml
penicillin
streptomycin
co
aed
albopictu
cell
kindli
donat
dr
celso
ramo
instituto
nacion
de
salud
cuernavaca
mexico
maintain
minimum
essenti
medium
mem
supplement
fetal
calf
serum
u
ml
penicillin
dengu
viru
serotyp
use
studi
kindli
provid
dr
alvaro
aguilarsetien
replic
cell
titrat
plaqu
assay
cell
serum
sampl
dengu
patient
collect
june
septemb
analyz
determin
serum
sampl
maintain
thaw
onto
ice
immedi
subject
elisa
patient
recruit
region
hospit
mepetec
puebla
mexico
patient
sign
dengu
fever
denv
infect
confirm
igm
antibodi
viral
antigen
detect
sampl
includ
patient
obtain
day
fever
onset
sampl
patient
inform
manag
perform
follow
ethic
regul
approv
local
research
health
ethic
committe
mexican
institut
social
secur
imss
protocol
accord
declar
helsinki
written
inform
consent
obtain
particip
control
serum
sampl
healthi
blood
donor
submit
convent
studi
hospit
blood
bank
use
compar
level
vero
cell
seed
onto
plate
infect
differ
viru
dose
quantifi
multipl
infect
moi
viral
inocula
incub
h
discard
cell
wash
twice
elimin
nonadsorb
viru
fresh
medium
sfb
ad
cell
incub
hour
day
depend
specif
assay
cell
treat
prior
infect
h
uiml
probiom
mexico
citi
mexico
ngml
peprotech
rocki
hill
nj
usa
ngml
peprotech
poli
c
invivogen
san
diego
ca
usa
control
treatment
perform
cell
use
dmem
without
sfb
poli
c
infect
cell
mockinfect
cell
previous
treat
mocktreat
ifn
h
analyz
order
determin
induct
total
extract
cell
obtain
h
postinfect
subject
sdspage
use
resolv
gel
protein
gel
transfer
pvdf
membran
detect
santa
cruz
biotechnolog
santa
cruz
ca
usa
abcam
cambridg
usa
specif
antibodi
abcam
primari
antibodi
reveal
goat
antirabbit
igghrp
santa
cruz
biotechnolog
rabbit
antigoat
igghrp
abcam
goat
antimous
igghrp
immobilon
western
chemiluminesc
system
milliporemerck
darmstadt
germani
cell
seed
onto
glass
chamber
slide
labtek
nalgen
nunc
rochest
ny
usa
infect
mention
infect
noninfect
control
wash
phosphatebuff
salin
pb
fix
ethanolaceton
vv
min
room
temperatur
cell
permeabil
min
order
detect
viral
prm
protein
insid
infect
cell
incub
block
solut
pb
fb
tween
cell
label
antidengu
viru
prm
antibodi
abcam
santa
cruz
biotechnolog
wash
incub
rabbit
antimous
iggtexa
red
abcam
bovin
antigoat
santa
cruz
biotechnolog
h
room
temperatur
dye
molecular
probe
eugen
usa
use
stain
nuclei
stain
cell
visual
laser
confoc
microscopi
system
use
imag
analysi
softwar
nikon
total
rna
infect
andor
stimul
cell
extract
use
trizol
invitrogen
carlsbad
ca
usa
accord
manufactur
instruct
treat
dnase
thermo
scientif
waltham
usa
quantifi
nm
revers
transcript
perform
use
revertaid
h
minu
revers
transcriptas
kit
thermo
scientif
random
hexam
reaction
program
min
min
min
obtain
cdna
use
amplifi
gene
use
taqman
univers
pcr
master
mix
amperas
ung
kit
appli
biosystem
foster
citi
ca
usa
gene
amplifi
use
maxima
sybr
greenrox
qpcr
master
mix
thermo
scientif
reaction
mixtur
contain
master
mix
nm
sens
antisens
primer
nm
taqman
probe
ng
rna
final
volum
forti
pcr
cycl
perform
case
hypoxanthin
guanin
phosphoribosyl
transferas
gene
use
intern
control
determin
rel
express
gene
primer
purchas
integr
dna
technolog
coralvil
ia
usa
obtain
ct
valu
analyz
method
express
level
report
proport
respect
control
sequenc
primer
probe
shown
tabl
level
serum
patient
measur
use
enzymelink
immunosorb
assay
elisa
kit
specif
r
system
inc
minneapoli
usa
elisa
perform
accord
manufactur
instruct
quantit
analys
perform
triplic
least
two
differ
assay
twoway
anova
bonferroni
test
perform
use
graphpad
prism
graphpad
softwar
la
jolla
ca
usa
differ
p
consid
statist
signific
